Cargando…

Personalized rate control treatment for atrial fibrillation: a prospective case-control study on the use of diltiazem

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Recent ESC Atrial Fibrillation guidelines introduced some changes in the options for rate control, such as the possibility to combine beta-blockers (BB) and non-dihydropyridine calcium channel blockers (NDCC), to address the need o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spadotto, A, Massaro, G, Amadori, M, Damaschin, L, Martignani, C, Ziacchi, M, Biffi, M, Galie, N, Boriani, G, Diemberger, I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	10.4.2 - Rate Control
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206795/ http://dx.doi.org/10.1093/europace/euad122.070

Ejemplares similares

Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial
por: Koldenhof, T, et al.
Publicado: (2023)

Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study
por: Diemberger, Igor, et al.
Publicado: (2022)

Incidence of conversion to sinus rhythm in refractory atrial fibrillation patients after atrioventricular node ablation with conduction system pacing
por: Ivanovski, M, et al.
Publicado: (2023)

Mid-term follow-up of atrioventricular node ablation and conduction system pacing without a ventricular backup lead in atrial fibrillation-induced tachycardiomyopathy - a single-center experience
por: Pestrea, C G, et al.
Publicado: (2023)

His bundle pacing and AV nodal ablation for non-controlled atrial arrhythmia: a technical challenge with major clinical benefits
por: Chaumont, C, et al.
Publicado: (2023)

An international two-centre experience with the third generation laser balloon system: safety, efficiency, and efficacy
por: Martignani, C, et al.
Publicado: (2023)

Evolution of surface and endocavitary signals in patients with arrhythmogenic cardiomyopathy at 1 and 5 years
por: Martignani, C, et al.
Publicado: (2023)

New left ventricular active fixation lead: The experience of lead extraction
por: Ziacchi, Matteo, et al.
Publicado: (2015)

Renal outcomes of early rhythm control in patients with atrial fibrillation and chronic kidney disease
por: Kim, D, et al.
Publicado: (2023)

Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads
por: Ziacchi, M., et al.
Publicado: (2018)

JK07 prevents atrial fibrosis and atrial fibrillation inducibility in a porcine DOCA model
por: Tubeeckx, M R L, et al.
Publicado: (2023)

Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only?
por: Biffi, Mauro, et al.
Publicado: (2016)

Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
por: Trinks-Roerdink, E M, et al.
Publicado: (2023)

Effects of antiarrhythmics on atrial high rate episodes and progression to clinical atrial fibrillation (ANTI-AHRE)
por: Simovic, S, et al.
Publicado: (2023)

The last shall be the first: the role of combined QLV- and CMR-determined electromechanical concordance in predicting optimal left ventricular stimulation site in cardiac resynchronisation therapy
por: Bertelli, M, et al.
Publicado: (2023)

Incremental value of continuous non-invasive blood pressure control to assess hypotension during atrial fibrillation ablation
por: Di Cori, A, et al.
Publicado: (2023)

Clinical application of virtual antiarrhythmic drug test using digital twins in patients who recurred atrial fibrillation after catheter ablation
por: Hwang, T, et al.
Publicado: (2023)

One-year outcomes in patients undergoing very high-power short-duration temperature-controlled ablation for atrial fibrillation
por: Strisciuglio, T, et al.
Publicado: (2023)

Effectiveness of electrical cardioversion for persistent atrial fibrillation in the ongoing protocolenergy: hawthorne effect trial
por: Jiravsky, O, et al.
Publicado: (2023)

Cardioversion strategy impacts quality of rate control during recurrences of atrial fibrillation
por: Van Der Velden, R, et al.
Publicado: (2023)

Novelty about pocket histology at cardiac implantable electronic device reopening procedures
por: Massaro, G, et al.
Publicado: (2023)

Role of diagnosis-to-ablation time in paroxysmal atrial fibrillation: preliminary results of the MULTI AF trial
por: Rossi, L, et al.
Publicado: (2023)

Telecardiology and Remote Monitoring of Implanted Electrical Devices: The Potential for Fresh Clinical Care Perspectives
por: Boriani, Giuseppe, et al.
Publicado: (2007)

Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database
por: Boriani, Giuseppe, et al.
Publicado: (2016)

Noninvasive continuous arterial pressure monitoring shortens atrial fibrillation ablation procedural duration
por: Parollo, M, et al.
Publicado: (2023)

Impact of the individual relationship between focal or rotational regions of interest and atrial cardiomyopathy in patients with chronic forms of atrial fibrillation
por: Guckel, D, et al.
Publicado: (2023)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Pulsed-field ablation: analysis of a new ablation technique for atrial fibrillation. A single centre experience
por: Sattin, T, et al.
Publicado: (2023)

Detection of the most dominant drivers of atrial fibrillation based on repetitive activity in sequential electro-anatomical mapping
por: Hermans, B J M, et al.
Publicado: (2023)

Incremental value of low-voltage area ablation in persistent atrial fibrillation: a systematic review and meta-analysis
por: Toumpourleka, M, et al.
Publicado: (2023)

Bone morphogenetic protein 10 as a predictor for recurrent atrial fibrillation after catheter ablation
por: Hennings, E, et al.
Publicado: (2023)

Outpatient atrial fibrillation ablation: feasibility, safety and economic implications
por: Jimenez-Candil, J, et al.
Publicado: (2023)

Catheter ablation as first-line treatment in patients with atrial fibrillation: a Bayesian network meta-analysis
por: Bonanno, C, et al.
Publicado: (2023)

Association of clinical characteristics and biomarkers with recurrent atrial fibrillation after hybrid ablation
por: Velt, M J H, et al.
Publicado: (2023)

Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus
por: Ahn, H J, et al.
Publicado: (2023)

Progression and regression in the left atrial substrate in patients with atrial fibrillation: the PROGRESS-AF study
por: Marcon, L, et al.
Publicado: (2023)

Identification of atrial complex electrograms by short-coupled extrastimuli in paroxysmal and persistent atrial fibrillation
por: Silva, E, et al.
Publicado: (2023)

Hybrid ablation of atrial fibrillation: long-term outcomes from a single center prospective experience
por: Mouram, S, et al.
Publicado: (2023)

Utility of intracardiac echocardiography during pulsed-field ablation of atrial fibrillation: preliminary experience in large multicenter clinical setting
por: Dello Russo, A, et al.
Publicado: (2023)

Effectiveness and safety of a time to isolation strategy of cryoballoon ablation of atrial fibrillation
por: Tsiachris, D, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ghus3bmkl4949gpkkmd8mvkrjl